New hope for dry AMD?

Dry age-related macular degeneration (AMD) is a major cause of vision loss in the elderly. Evans and Syed discuss the pipeline of therapies for dry AMD and the future of the market.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature reviews. Drug discovery 2013-07, Vol.12 (7), p.501-502
Hauptverfasser:	Evans, James B., Syed, Basharut A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomedicine Biotechnology Cancer Research Causes of Clinical Trials as Topic Development and progression Drug Discovery - methods Eye diseases from-the-analysts-couch Humans Macular degeneration Macular Degeneration - drug therapy Macular Degeneration - genetics Macular Degeneration - immunology Macular Degeneration - physiopathology Medicinal Chemistry Molecular Medicine Molecular Targeted Therapy - methods Pharmacology/Toxicology Risk factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Dry age-related macular degeneration (AMD) is a major cause of vision loss in the elderly. Evans and Syed discuss the pipeline of therapies for dry AMD and the future of the market.
ISSN:	1474-1776 1474-1784
DOI:	10.1038/nrd4038